Background: Few pathological data have focused on the causal link between intracranial atherosclerotic disease and parent artery stroke. The objective of this study was to investigate the cause of middle cerebral artery (MCA) atherosclerotic disease in patients with fatal stroke. Methods and Results: In 123 patients with unilateral MCA territory infarction we performed a case-control autopsy study evaluating the frequency of atherosclerotic plaque and moderate (<70%) or severe (≧70%) stenosis in the ipsilateral and contralateral MCA. Clinical history, risk factors, imaging data and general autopsy reports were available. The entire cerebral arterial tree was studied pathologically. MCA atherosclerosis (either moderate or severe stenosis) was more frequent in the ipsilateral (21.1%, n = 26) than the contralateral MCA (8.1%, n = 10). The corresponding odds ratio (OR) for the presence of atherosclerosis in the ipsilateral MCA relative to the contralateral MCA was 6.33 [95% confidence interval (CI) = 1.87–21.40]. This difference was found with both moderate (OR = 5.75, 95% CI = 1.45–22.76) and severe (OR = 7.18, 95% CI = 1.58–32.73) stenosis. Conclusions: Moderate MCA atherosclerotic stenosis may be responsible for parent territorial stroke. Novel arterial wall magnetic resonance imaging techniques should now be used to investigate in vivo the hypothesis that moderate MCA stenosis is a possible explanation in patients with nonfatal stroke of unknown cause.

Keywords:
Middle cerebral artery atherosclerosis, Parent artery disease, Stroke
1.
Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14–20.
2.
Thijs VN, Albers GW: Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490–497.
3.
Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F: Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006;66:1187–1191.
4.
Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med2005;352:1305–1316.
5.
Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555–563.
6.
Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P: Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 2008;39:1142–1147.
7.
Caplan LR: Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 1989;39:1246–1250.
8.
Klein IF, Lavallée PC, Schouman-Claeys E, Amarenco P: High-resolution MRI identifies basilar artery plaques in paramedian pontine infarct. Neurology 2005;64:551–552.
9.
Bang OY, Heo JH, Kim JY, Park JH, Huh K: Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction. Arch Neurol 2002;59:259–263.
10.
Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;326:221–225.
11.
Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul PJ, Bousser MG: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331:1474–1479.
12.
Jaramillo A, Gongora-Rivera F, Labreuche J, Hauw JJ, Amarenco P: Predictors for malignant middle cerebral artery infarctions: a postmortem analysis. Neurology 2006;66:815–820.
13.
Touboul PJ, Elbaz A, Koller C, Lucas C, Adrai V, Chedru F, Amarenco P: Common carotid artery intima-media thickness and brain infarction: the Étude du Profil Génétique de l’Infarctus Cérébral (GÉNIC) case-control study. The GENIC Investigators. Circulation 2000;102:313–318.
14.
Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB: The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988;19:547–554.
15.
Klein IF, Lavallée PC, Touboul PJ, Schouman-Claeys E, Amarenco P: In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology 2006;67:327–329.
16.
Swartz RH, Bhuta SS, Farb RI, Agid R, Willinsky RA, Terbrugge KG, Butany J, Wasserman BA, Johnstone DM, Silver FL, Mikulis DJ: Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology 2009;72:627–634.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.